EnterohemorrhagicEscherichia coli (EHEC) in Pediatric Hemolytic-Uremic Syndrome: A Prospedtive Study in Germany and Austria*
暂无分享,去创建一个
[1] L. Beutin,et al. Human infections with Shiga toxin-producing Escherichia coli other than serogroup O157 in Germany. , 1998, Emerging infectious diseases.
[2] H. Lior,et al. Risk of hemolytic uremic syndrome after sporadic Escherichia coli O157:H7 infection: results of a Canadian collaborative study. Investigators of the Canadian Pediatric Kidney Disease Research Center. , 1998, The Journal of pediatrics.
[3] James P. Nataro,et al. Diarrheagenic Escherichia coli , 1998, Clinical Microbiology Reviews.
[4] I. Capek,et al. Possible person-to-person transmission of Escherichia coli O111 – associated hemolytic uremic syndrome , 1997, Pediatric Nephrology.
[5] M. Bitzan,et al. Immune response to non-O157 Vero toxin-producing Escherichia coli in patients with hemolytic uremic syndrome. , 1996, The Journal of infectious diseases.
[6] P. Tarr,et al. Perspective: the problem of non-O157:H7 shiga toxin (Verocytotoxin)-producing Escherichia coli. , 1996, The Journal of infectious diseases.
[7] J. H. Green,et al. Shiga-like toxin-producing Escherichia coli O111 and associated hemolytic-uremic syndrome: a family outbreak. , 1996, The Pediatric infectious disease journal.
[8] A. Stapleton,et al. Hemolytic-uremic syndrome in a six-year-old girl after a urinary tract infection with Shiga-toxin-producing Escherichia coli O103:H2. , 1996, The New England journal of medicine.
[9] M. Falk,et al. Survey of haemolytic‐uraemic syndrome in Queensland 1979–1995 , 1996, The Medical journal of Australia.
[10] A. Pavia,et al. Atypical hemolytic-uremic syndrome: a comparison with postdiarrheal disease. , 1996, The Journal of pediatrics.
[11] D. Busch,et al. Diarrhea in young children associated with Escherichia coli non-O157 organisms that produce Shiga-like toxin. , 1996, The Journal of pediatrics.
[12] H. Karch,et al. Isolation of enterohemorrhagic Escherichia coli O157 strains from patients with hemolytic-uremic syndrome by using immunomagnetic separation, DNA-based methods, and direct culture , 1996, Journal of clinical microbiology.
[13] M. Levine,et al. Sorbitol-negative phenotype among enterohemorrhagic Escherichia coli strains of different serotypes and from different sources , 1995, Journal of clinical microbiology.
[14] A. Caprioli,et al. Genotyping of Shiga-like toxin genes in non-O157 Escherichia coli strains associated with haemolytic uraemic syndrome. , 1995, Journal of medical microbiology.
[15] P. Tarr. Escherichia coli 0157:H7: Clinical, Diagnostic, and Epidemiological Aspects of Human Infection , 1995 .
[16] P. Dennehy,et al. A Prospective Study of Shiga‐Like Toxin‐Associated Diarrhea in a Pediatric Population , 1994, Journal of pediatric gastroenterology and nutrition.
[17] H. Karch,et al. Prevalence of attaching and effacing Escherichia coli in stool samples from patients and controls. , 1994, Zentralblatt fur Bakteriologie : international journal of medical microbiology.
[18] L. Beutin,et al. The large-sized plasmids of enterohemorrhagic Escherichia coli O157 strains encode hemolysins which are presumably members of the E. coli alpha-hemolysin family. , 1994, FEMS microbiology letters.
[19] A. Edefonti,et al. Communitywide Outbreak of Hemolytic-Uremic Syndrome Associated with Non-O157 Verocytotoxin-Producing Escherichia coli , 1994 .
[20] J. Heesemann,et al. Clonal structure and pathogenicity of Shiga-like toxin-producing, sorbitol-fermenting Escherichia coli O157:H- , 1993, Journal of clinical microbiology.
[21] H. König,et al. The role of Escherichia coli O 157 infections in the classical (enteropathic) haemolytic uraemic syndrome: Results of a Central European, multicentre study , 1993, Epidemiology and Infection.
[22] M. Hossain,et al. The bimodal mortality pattern of acute renal failure in children. , 1993, Renal failure.
[23] A. Caprioli,et al. Hemolytic-Uremic Syndrome and Vero Cytotoxin-Producing Escherichia coli Infection in Italy , 1992 .
[24] H. Karch,et al. Serological and biochemical properties of Shiga-like toxin (verocytotoxin)-producing strains of Escherichia coli, other than O-group 157, from patients in Germany. , 1992, Zentralblatt fur Bakteriologie : international journal of medical microbiology.
[25] H. Karch,et al. High incidence of serum antibodies to Escherichia coli O157 lipopolysaccharide in children with hemolytic-uremic syndrome. , 1991, The Journal of pediatrics.
[26] E. Orrbine,et al. Epidemiology of hemolytic-uremic syndrome in Canadian children from 1986 to 1988. The Canadian Pediatric Kidney Disease Reference Centre. , 1991, The Journal of pediatrics.
[27] H R Smith,et al. Haemolytic uraemic syndromes in the British Isles, 1985-8: association with verocytotoxin producing Escherichia coli. Part 2: Microbiological aspects. , 1990, Archives of disease in childhood.
[28] B Rowe,et al. Haemolytic uraemic syndromes in the British Isles 1985-8: association with verocytotoxin producing Escherichia coli. Part 1: Clinical and epidemiological aspects. , 1990, Archives of disease in childhood.
[29] L. Pickering,et al. Hemolytic uremic syndrome and diarrhea in Argentine children: the role of Shiga-like toxins. , 1989, The Journal of infectious diseases.
[30] M. Petric,et al. SPORADIC CASES OF HAEMOLYTIC-URAEMIC SYNDROME ASSOCIATED WITH FAECAL CYTOTOXIN AND CYTOTOXIN-PRODUCING ESCHERICHIA COLI IN STOOLS , 1983, The Lancet.
[31] J. L. López Gómez,et al. [Hemolytic uremic syndrome in childhood]. , 1982, Revista clinica espanola.
[32] R. Siegler,et al. The hemolytic-uremic syndrome. , 2017, The Western journal of medicine.
[33] J. Dalrymple,et al. Quantitative microtiter cytotoxicity assay for Shigella toxin , 1980, Journal of clinical microbiology.